Newm-035 💫 🔔

The drug was developed by , a spinoff from Kyoto University, led by Dr. Katsu Takahashi.

: The drug targets a specific protein called USAG-1 (uterine sensitization-associated gene-1). In nature, USAG-1 acts as a "biological parking brake" that prevents dormant tooth buds in the human jaw from developing into full teeth after the adult set has grown. NEWM-035

Below is an overview of the development and science behind . TRG-035: The World's First Tooth Regrowth Drug The drug was developed by , a spinoff

TRG-035 is a monoclonal antibody designed to stimulate the growth of a "third set" of teeth in humans who have lost them due to decay, injury, or congenital conditions. The drug was developed by